Stock Trading at Merrimack Pharmaceuticals Inc. (MACK): J. Robert Mulroy buys 280,168 sharesBy Pamela GavinoAugust 25, 2014 Merrimack Pharmaceuticals Inc. (NASDAQ:MACK)’s President and Chief Executive Officer J. Robert Mulroy used some stock options on August 21st. to acquire…